期刊文献+

复发性卵巢上皮癌治疗策略

The therapy strategy of the recurrence epithelia ovarian carcinoma
原文传递
导出
摘要 卵巢上皮癌的发病率高,复发率也高。针对复发性卵巢上皮癌的不同情况,可选择性地给予手术治疗,并辅以合适的化疗及生物治疗。尽可能地改善患者的生存质量,延长生存时间,对其不同治疗方法的进行作一简要综述。 The incidence rate of epithelia ovarian cancer is high. The recurrence rate is also high. To improve the survival quality of patients and extend their life time as far as possible, and according to the recurrence epithelia ovarian carcinoma's different situation, we can selectively perform surgery, and combined it with appropriate chemotherapy and biological treatment. This article summarized its treatment from surgery, chemotherapy and biological therapy, these three aspects.
出处 《肿瘤研究与临床》 CAS 2009年第4期286-288,共3页 Cancer Research and Clinic
关键词 卵巢肿瘤 抗肿瘤联合化疗方案 治疗 Ovarian neoplasms Antineoplastic combined chemotherapy protocols Therapy
  • 相关文献

参考文献18

  • 1Alberts DS, Hannigan EV, Liu PY, et al. Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy:an intergroup study. Gynecol Ncol, 2006,100: 133-138. 被引量:1
  • 2辛晓燕,王健,陈必良,严瑞兰,杨红,刘淑娟.复发性卵巢上皮性癌再次手术与化疗的临床价值[J].中国肿瘤临床,2001,28(4):259-261. 被引量:9
  • 3Pfisterer J, Harter P, Canzle V, et al. The role of surgery in recurrent ovarian cancer. Int J Gynecol Cancer, 2005, 15: 195-198. 被引量:1
  • 4Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreactive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer, 2000, 88: 144-153. 被引量:1
  • 5马玲,张竞,姚婷婷.复发性卵巢癌治疗方法的选择[J].蚌埠医学院学报,2008,33(4):414-415. 被引量:1
  • 6By Don S, Dizon, Martee L, Hensley. Elizabeth A, et al.Retrospective analysis of carboplatin and paclitaxel as initial second-line therpy for recurrent epithelial ovarian carcinoma:appIication toward a dynamic disease state model of ovarian cancer. Journal of Clinical Oncolgy, 2002, 20: 1238-1247. 被引量:1
  • 7童成礼,翁国爱.紫杉醇联合奥沙利铂治疗复治晚期卵巢癌26例[J].肿瘤研究与临床,2006,18(3):194-195. 被引量:2
  • 8余冬青,李力.复发性卵巢癌二线化疗临床价值的循证评价[J].实用癌症杂志,2005,20(3):273-277. 被引量:5
  • 9Windbichler GH, Husmaninger H, Stummvoll W, et al.Interferon-gamma in the first-line therapy of ovarian cancer: randomized phase IIl trail. British Journal of cancer, 2000, 82: 1138-1144. 被引量:1
  • 10Marth C, Windbichler GH, Hausmaninger H, et al. Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer:results of a phase I/II study. Int J Gynecol Cancer, 2006, 16: 1522-1528. 被引量:1

二级参考文献58

  • 1高永良.复发性卵巢癌的诊疗新策略[J].国外医学(妇产科学分册),2004,31(4):203-204. 被引量:4
  • 2陈沂,吴绪峰,陈惠祯.复发性卵巢癌的研究进展[J].国外医学(肿瘤学分册),2004,31(12):946-949. 被引量:6
  • 3陈小祥,孙志华,吴强,汪振诚.HSV-TK/GCV系统在难治性卵巢癌裸鼠移植瘤模型中的实验研究[J].现代妇产科进展,2006,15(7):497-501. 被引量:3
  • 4连利娟.林巧稚妇科肿瘤(第二版)[M].北京:人民卫生出版社,1982.489. 被引量:1
  • 5Parmar MK,Ledermann JA,Colombo N,et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2. 2 trial[J].Lancet, 2003,361 (9375) : 2099. 被引量:1
  • 6Dizon DS,Dupont J, Anderson S, et al. Treatment of recurrent ovarian cancer-a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience[J]. Gynecol Oncol,2003,91(3):584. 被引量:1
  • 7Thigpen JT, Blessing JA, Olt G, et al. Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study[J]. Gynecol Oncol, 2003,90(3) : 581. 被引量:1
  • 8Gronlund B, Hansen HH, Hogdall C, et al. Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma[J]. Cancer, 2002, 95(8) : 1656. 被引量:1
  • 9Balbi G, Di Prisco L, Musone R, et al. Second-line with paclitaxel and carboplatin for recurrent disease following first paclitaxel and platinum compounds in ovarian carcinoma[J]. Eur J Gynaecol Oncol, 2002,23 (4) : 347. 被引量:1
  • 10Gershenson DM. Irinotecan in epithelial ovarian cancer[J]. Oncology(Huntingt) ,2002,16(5 Suppl 5) :29. 被引量:1

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部